ACF Expands Access to Medications for Opioid Use Disorder for At-Risk Families

ACF Expands Access to Medications for Opioid Use Disorder for At-Risk Families | The Administration for Children and Families

Topline: Buprenorphine, methadone, and naltrexone now eligible as “well-supported” interventions to increase access to evidence-based substance use disorder treatment for families at risk.